X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2649) 2649
science & technology (2271) 2271
life sciences & biomedicine (2221) 2221
cerebral hemorrhage - chemically induced (2033) 2033
male (1927) 1927
female (1634) 1634
neurosciences & neurology (1282) 1282
middle aged (1084) 1084
aged (1056) 1056
clinical neurology (952) 952
animals (833) 833
adult (746) 746
stroke (651) 651
risk factors (635) 635
abridged index medicus (602) 602
cardiovascular system & cardiology (565) 565
anticoagulants - adverse effects (534) 534
neurosciences (533) 533
treatment outcome (477) 477
peripheral vascular disease (474) 474
rats (440) 440
aged, 80 and over (435) 435
fibrinolytic agents - adverse effects (408) 408
tissue plasminogen activator - adverse effects (403) 403
stroke - drug therapy (392) 392
time factors (390) 390
neurology (375) 375
intracerebral hemorrhage (355) 355
tomography, x-ray computed (352) 352
hemorrhage (347) 347
disease models, animal (326) 326
retrospective studies (323) 323
general & internal medicine (320) 320
thrombolytic therapy - adverse effects (300) 300
brain ischemia - drug therapy (264) 264
cerebral hemorrhage - pathology (262) 262
hemorrhage - chemically induced (260) 260
anticoagulants - therapeutic use (246) 246
fibrinolytic agents - therapeutic use (245) 245
medicine, general & internal (239) 239
rats, sprague-dawley (239) 239
ischemia (236) 236
tissue plasminogen activator - therapeutic use (236) 236
magnetic resonance imaging (234) 234
cerebral hemorrhage - epidemiology (233) 233
surgery (220) 220
platelet aggregation inhibitors - adverse effects (218) 218
warfarin - adverse effects (216) 216
cerebral hemorrhage - diagnostic imaging (212) 212
thrombolysis (207) 207
brain - pathology (203) 203
tissue plasminogen activator - administration & dosage (199) 199
brain (194) 194
fibrinolytic agents - administration & dosage (192) 192
anticoagulants (190) 190
dose-response relationship, drug (186) 186
care and treatment (184) 184
cerebral angiography (184) 184
analysis (180) 180
cerebral hemorrhage - diagnosis (180) 180
mice (179) 179
prospective studies (179) 179
anticoagulants - administration & dosage (177) 177
adolescent (175) 175
cerebral infarction (174) 174
medicine & public health (174) 174
cerebral hemorrhage - physiopathology (171) 171
cerebral hemorrhage - drug therapy (168) 168
aspirin - adverse effects (167) 167
infant, newborn (164) 164
cerebral hemorrhage - etiology (162) 162
risk assessment (160) 160
mortality (159) 159
cerebral hemorrhage - mortality (158) 158
cerebral hemorrhage - complications (154) 154
pregnancy (152) 152
acute disease (151) 151
cerebral hemorrhage - prevention & control (151) 151
warfarin (146) 146
drug therapy, combination (145) 145
health aspects (145) 145
research (143) 143
thrombolytic therapy (142) 142
stroke - etiology (141) 141
cerebral hemorrhage (139) 139
drug therapy (138) 138
follow-up studies (137) 137
platelet aggregation inhibitors - therapeutic use (137) 137
tissue plasminogen activator (135) 135
risk (134) 134
hematology (133) 133
stroke - prevention & control (133) 133
heparin - adverse effects (131) 131
cardiac & cardiovascular systems (130) 130
cardiovascular diseases (129) 129
myocardial infarction - drug therapy (124) 124
patients (124) 124
prognosis (124) 124
myocardial infarction (121) 121
pharmacology & pharmacy (121) 121
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3095) 3095
German (103) 103
French (73) 73
Spanish (55) 55
Japanese (52) 52
Swedish (16) 16
Chinese (11) 11
Dutch (10) 10
Danish (8) 8
Italian (8) 8
Russian (7) 7
Norwegian (6) 6
Polish (6) 6
Hungarian (2) 2
Finnish (1) 1
Romanian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10038, pp. 2605 - 2613
Journal Article
Journal Article
Journal Article
Stroke (1970), ISSN 0039-2499, 06/2012, Volume 43, Issue 6, pp. 1524 - 1531
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2016, Volume 375, Issue 18, pp. 1717 - 1725
Three patients had severe ataxia and memory impairment in a phase 1 trial of a fatty acid amide hydrolase inhibitor designed as an analgesic and... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Middle Aged | Male | Cyclic N-Oxides - administration & dosage | Healthy Volunteers | Cerebral Hemorrhage - diagnosis | Pyridines - adverse effects | Cyclic N-Oxides - adverse effects | Adult | Headache - chemically induced | Brain Death | Cerebral Hemorrhage - chemically induced | Acute Disease | Pons - pathology | Pyridines - administration & dosage | Double-Blind Method | Administration, Oral | Amidohydrolases - antagonists & inhibitors | Hippocampus - pathology | Cerebellum - pathology | Consciousness Disorders - chemically induced | Magnetic Resonance Imaging | Cerebellar Diseases - chemically induced | Gait Ataxia - chemically induced | Memory Disorders - chemically induced | Nervous system diseases | Care and treatment | Dosage and administration | Drug testing | Acetylaminofluorene | Fatty-acid amide hydrolase | Cerebellum | Neuroimaging | Headache | Enzymes | Pons | Animal models | Inhibitor drugs | Hydrolase | Toxicity | Memory | Oral administration | Fatty acids | Patients | Cannabinoids | Magnetic resonance imaging | Patient safety | Drug dosages | Hippocampus | Neurological disorders | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Neurons and Cognition | Psychiatrics and mental health
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2012, Volume 366, Issue 15, pp. 1404 - 1413
.... After 2 years, the data and safety monitoring board recommended discontinuation of the study treatment in patients with a history of stroke owing to the risk of intracranial hemorrhage. RESULTS... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Index Medicus | Abridged Index Medicus | Computer Science | Medical Imaging
Journal Article
The New England journal of medicine, ISSN 1533-4406, 01/2017, Volume 376, Issue 2, pp. 136 - 148
Journal Article
Journal Article